Form 4: Certara Inc. Executive Patrick F. Smith Reports Stock Transactions

Patrick F. Smith, President of Drug Development Solutions at Certara, Inc., reports the vesting and settlement of restricted stock units and related tax withholding.

Summary

• On October 4, 2024, Patrick F. Smith, President of Drug Development Solutions at Certara, Inc., had restricted stock units (RSUs) vest and settle.
• 7,151 RSUs vested and were settled, converting into common stock.
• 1,742 shares were withheld to cover tax obligations related to the vesting of the RSUs.
• Following these transactions, Smith directly owns 55,500 shares of Certara common stock.
• Smith also holds 14,303 restricted stock units.
• A power of attorney is in place, authorizing Daniel Corcoran, John B. Hoffman, and Margaret A. Peter to file SEC forms on Smith's behalf.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a standard reporting of stock transactions related to executive compensation.

Future Outlook

Two-thirds of the RSUs are scheduled to vest and settle in equal parts on October 5, 2025, and October 5, 2026.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect the standard compensation practices of the company.

Key Dates